Shared genetic architecture between grip strength and cognitive function: insights from large-scale genome-wide...

Aging populations frequently experience concurrent declines in physical robustness and mental acuity, creating a significant burden on healthcare systems and individual quality of life. Prior research has shown that grip strength serves as a reliable proxy for overall muscular health and biological age, often predicting long-term mortality and disability. Epidemiological observations frequently link reduced handgrip force with accelerated cognitive impairment in elderly cohorts, yet the underlying biological drivers remain poorly understood by the scientific community. Geneticists suspect that shared biological pathways or pleiotropic effects underpin these seemingly disparate physiological systems during the natural aging process. Understanding the common genomic variants could reveal why these traits often deteriorate in tandem and whether they share a causal root or simply a common regulatory framework. This absence of evidence motivated a large-scale investigation into the shared genetic architecture between these phenotypes using advanced bioinformatic tools and massive summary-level datasets.

This investigation seeks to delineate the shared genetic architecture between grip strength and five distinct cognitive function-related traits to uncover common biological roots. Researchers aimed to identify specific pleiotropic loci that influence both muscular performance and neurological processing across large populations to improve diagnostic accuracy. The study intended to map novel Single Nucleotide Polymorphisms (SNPs) that contribute to the heritability of these trait pairs while filtering out non-significant noise through rigorous statistical thresholds. Scientists sought to uncover the specific immune cells and tissues where these shared genetic signals are most active to understand systemic aging and potential inflammatory triggers. The project also aimed to evaluate potential drug targets that might simultaneously address physical and cognitive decline by leveraging summary-level genomic data from diverse sources. By integrating multiple datasets, the team worked to clarify the molecular mechanisms linking physical strength to brain health for future clinical applications and therapeutic development.

The research team used large-scale Genome-Wide Association Study (GWAS) summary-level datasets to perform cross-trait pleiotropic analysis across multiple phenotypic categories and diverse cohorts. Functional Mapping and Annotation (FUMA) and Multi-marker Analysis of GenoMic Annotation (MAGMA) were employed to characterize the identified genomic risk loci and map them to functional genes. Summary-data-based Mendelian Randomization (SMR) allowed the investigators to explore potential drug targets within European populations by linking gene expression to trait outcomes through instrumental variables. The Pleiotropic Analysis under Composite null hypothesis (PLACO) method facilitated the detection of shared genetic signals across the various phenotypes with high statistical rigor and sensitivity. Heritance enrichment analysis was conducted to pinpoint specific immune cells and tissues involved in the trait interactions, providing a systemic view of the genetic influence. Hypothesis Prioritization in multi-trait Colocalization (HyPrColoc) served to validate the immune mechanisms associated with the trait pairs by assessing the probability of shared causal variants at specific loci.

The analysis identified 20 novel Single Nucleotide Polymorphism (SNP) loci reaching a significance threshold of P < 5 × 10⁻⁸/5, indicating robust genetic associations across the studied traits. Seven pleiotropic genomic risk loci were discovered, including the previously noted regions at 1p34.2 and 4q24, which reinforce the validity of the cross-trait approach used by the team. Gene-level assessments highlighted seven unique pleiotropic genes that influence both traits. Specifically, the team named B-cell scaffold protein with ankyrin repeats 1 (BANK1), cell adhesion molecule 2 (CADM2), AF4/FMR2 family member 3 (AFF3), and activator of transcription and developmental regulator (AUTS2) as key players. Integration of PLACO, FUMA, MAGMA, and SMR results yielded four novel drug targets identified within the European study population that align with the pleiotropic genetic findings. Tissue-specific analyses confirmed that the identified pleiotropic genes exert significant influence across various biological systems, particularly within the central nervous system and musculoskeletal tissues. Validation via HyPrColoc supported the presence of specific immune mechanisms that link grip strength to cognitive performance, suggesting an inflammatory component to the aging process.

These findings provide a comprehensive map of the genetic overlap between muscular strength and cognitive processing, offering a new framework for geriatric research and intervention. The identification of novel SNPs and pleiotropic genes offers a foundation for future mechanistic studies in gerontology and personalized medicine for aging populations. Targeting the shared pathways involving BANK1 or CADM2 might lead to interventions that preserve both physical and mental function as individuals age. The discovery of four novel drug targets suggests new pharmacological avenues for treating age-related decline that were previously unrecognized in clinical settings. Future research should investigate how these specific immune cells modulate the relationship between muscle and brain health to develop targeted therapies that address systemic decline. This study advances our understanding of the molecular underpinnings that govern healthy aging across multiple physiological domains, highlighting the importance of cross-trait genomic analysis in modern biology.